ZFIN Publication List

Lasa-Fernandez, H., Mosqueira-Martín, L., Alzualde, A., Lasa-Elgarresta, J., Vallejo-Illarramendi, A. (2020) A genotyping method combining primer competition PCR with HRM analysis to identify point mutations in Duchenne animal models. Scientific Reports. 10:17224

Spinazzola, J.M., Lambert, M.R., Gibbs, D.E., Conner, J.R., Krikorian, G.L., Pareek, P., Rago, C., Kunkel, L.M. (2020) Effect of serotonin modulation on dystrophin-deficient zebrafish. Biology Open. 9(8):

Hightower, R.M., Reid, A.L., Gibbs, D.E., Wang, Y., Widrick, J.J., Kunkel, L.M., Kastenschmidt, J.M., Villalta, S.A., van Groen, T., Chang, H., Gornisiewicz, S., Landesman, Y., Tamir, S., Alexander, M.S. (2019) The SINE Compound KPT-350 Blocks Dystrophic Pathologies in DMD Zebrafish and Mice. Molecular therapy : the journal of the American Society of Gene Therapy. 28(1):189-201

Bajanca, F., Vandel, L. (2017) Epigenetic Regulators Modulate Muscle Damage in Duchenne Muscular Dystrophy Model. PLoS Currents. 9

Goody, M., Jurczyszak, D., Kim, C., Henry, C. (2017) Influenza A Virus Infection Damages Zebrafish Skeletal Muscle and Exacerbates Disease in Zebrafish Modeling Duchenne Muscular Dystrophy. PLoS Currents. 9

Schiavone, M., Zulian, A., Menazza, S., Petronilli, V., Argenton, F., Merlini, L., Sabatelli, P., Bernardi, P. (2017) Alisporivir rescues defective mitochondrial respiration in Duchenne muscular dystrophy. Pharmacological research. 125(Pt B):122-131

Lipscomb, L., Piggott, R.W., Emmerson, T., Winder, S.J. (2016) Dasatinib as a treatment for Duchenne muscular dystrophy. Human molecular genetics. 25(2):266-74

Widrick, J.J., Alexander, M., Sanchez, B., Gibbs, D., Kawahara, G., Beggs, A., Kunkel, L. (2016) Muscle dysfunction in a zebrafish model of Duchenne muscular dystrophy. Physiological Genomics. 48(11):850-860

Vieira, N.M., Elvers, I., Alexander, M.S., Moreira, Y.B., Eran, A., Gomes, J.P., Marshall, J.L., Karlsson, E.K., Verjovski-Almeida, S., Lindblad-Toh, K., Kunkel, L.M., Zatz, M. (2015) Jagged 1 Rescues the Duchenne Muscular Dystrophy Phenotype. Cell. 163:1204-13

Li, M., Andersson-Lendahl, M., Sejersen, T., and Arner, A. (2014) Muscle dysfunction and structural defects of dystrophin-null sapje mutant zebrafish larvae are rescued by ataluren treatment. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 34(Suppl2):116-122

Johnson, N.M., Farr, G.H., and Maves, L. (2013) The HDAC Inhibitor TSA Ameliorates a Zebrafish Model of Duchenne Muscular Dystrophy. PLoS Currents. 5:157-71

Kawahara, G., Karpf, J.A., Myers, J.A., Alexander, M.S., Guyon, J.R., and Kunkel, L.M. (2011) Drug screening in a zebrafish model of Duchenne muscular dystrophy. Proceedings of the National Academy of Sciences of the United States of America. 108(13):5331-6